Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin and LMWH for Repeated Implantation Failures in IVF
NCT01924104Phase 3Unknown
- Start
- Aug 2013
- Primary completion
- Aug 2014
- Modality
- Recombinant Proteins and Enzymes, Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of low molecular weight heparin calcium and aspirin in Repeated Implantation Failure (RIF) (4 arms). Primary endpoint: Biological pregnancy test at 14 days. Status: unknown.
02
Drugs
low molecular weight heparin calciumaspirin
03
Conditions
Repeated Implantation Failure (RIF)
Beyond the preview
Go deeper on NCT01924104.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01924104.